4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-20-002874
EXECUTIVE CHAIRMAN OF BOARD sold 37,829 shares at $5.19 ($196,333)
- EXECUTIVE CHAIRMAN OF BOARD acquired 41,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jaksch Frank L Jr · EXECUTIVE CHAIRMAN OF BOARD
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-10 | Exercise or conversion : show line 1 in the form | +41,667 | $4.62 | $192,502 | 262,168 | D |
| 2020-12-10 | Sale : show line 2 in the form | −37,829 | $5.19 | $196,333 | 224,339 | D |
| Open-market sales · 37,829 sh · avg $5.19 · $196,333 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-10 | Exercise or conversion : show line 3 in the form Employee Stock Options (right to buy) | −41,667 | 0 | D |
Loading xslF345X03/form4-12112020_021211.xml…